A new study has found no evidence that ibuprofen, Xeljanz (tofacitinib) or other non-steroidal anti-inflammatory drugs (NSAIDs), TNF blockers or JAK inhibitors...
Tag - tofacitinib
A recent meta-analysis determined that patients with inflammatory bowel disease (IBD) who take Janus Kinase (JAK) inhibitors may face an increased risk of...
Healthcare data analysis firm 3 Axis Advisors expects the price of arthritis medication Xeljanz to increase by about five percent in 2020.
Xeljanz is used to...